This is a profile image of Josie Zhou

Josie Zhou


Helps pharmaceutical and biotechnology companies drive value creation across R&D and commercial topics in greater China; leads the firm’s biotechnology work in China

Josie has extensive experiences serving global and local biopharmaceutical clients across a broad range of topics in China. She has a focus on R&D, business development and strategic partnership, launch and growth strategy, and commercial model innovation.

Her recent work includes the following:

  • assessing IPO readiness and crafting equity story for leading China-originated biotechnology companies
  • developing a winning franchise strategy in China
  • supporting cross-border business development and strategic partnerships
  • designing and building innovative digital-enabled business models and products from omnichannel physician engagement to digitally enabled patient activation and engagement.

Josie is a regular speaker at leading industry conferences in China, and she has authored articles on healthcare innovation and hosted regular executive roundtables for China’s biotech leaders.


Vision 2028: How China could impact the global biopharma industry,” McKinsey & Company, August 2022

The dawn of China biopharma innovation,” McKinsey & Company, October 2021

How COVID-19 changes the game for biopharma in China,” McKinsey & Company, April 2020

What’s next for pharma innovation in China,” McKinsey & Company, September, 2017


University of California
PhD, molecular biology

University of Science and Technology of China
BS, cell biology